EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Brain Stimulation, Nanomedicine and the Use of Magnetoelectric Nanoparticles: Dopaminergic Alterations and Their Role in Neurodegeneration and Drug Addiction

Silvia Giménez, Alexandra Millan, Alba Mora-Morell, Noa Ayuso, Isis Gastaldo-Jordán iD, Marta Pardo iD

Molecules · 2024

DOI: 10.3390/molecules29153580 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2024. Verfasst von Silvia Giménez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychobiology, Universidad de Valencia, 46010 Valencia, Spain. Hauptthemen laut MEDLINE: Nanomedicine, Neurodegenerative Diseases, Substance-Related Disorders, Dopamine. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 224 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades, Ministerio de Ciencia e Innovación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent advancements in brain stimulation and nanomedicine have ushered in a new era of therapeutic interventions for psychiatric and neurodegenerative disorders. This review explores the cutting-edge innovations in brain stimulation techniques, including their applications in alleviating symptoms of main neurodegenerative disorders and addiction. Deep Brain Stimulation (DBS) is an FDA-approved treatment for specific neurodegenerative disorders, including Parkinson’s Disease (PD), and is currently under evaluation for other conditions, such as Alzheimer’s Disease. This technique has facilitated significant advancements in understanding brain electrical circuitry by enabling targeted brain stimulation and providing insights into neural network function and dysfunction. In reviewing DBS studies, this review places particular emphasis on the underlying main neurotransmitter modifications and their specific brain area location, particularly focusing on the dopaminergic system, which plays a critical role in these conditions. Furthermore, this review delves into the groundbreaking developments in nanomedicine, highlighting how nanotechnology can be utilized to target aberrant signaling in neurodegenerative diseases, with a specific focus on the dopaminergic system. The discussion extends to emerging technologies such as magnetoelectric nanoparticles (MENPs), which represent a novel intersection between nanoformulation and brain stimulation approaches. These innovative technologies offer promising avenues for enhancing the precision and effectiveness of treatments by enabling the non-invasive, targeted delivery of therapeutic agents as well as on-site, on-demand stimulation. By integrating insights from recent research and technological advances, this review aims to provide a comprehensive understanding of how brain stimulation and nanomedicine can be synergistically applied to address complex neuropsychiatric and neurodegenerative disorders, paving the way for future therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanomedicineNeurodegenerative DiseasesSubstance-Related DisordersDopamineDeep Brain StimulationHumansAnimalsNanoparticlesBrain

Stichwörter der Autor:innen

addictionbrain stimulationdopaminemagnetoelectric nanoparticlesnanomedicineneurodegeneration

Substanzen

Dopamine

Autor:innen und Institutionen

  • Department of Psychobiology, Universidad de Valencia, 46010 Valencia, Spain.
  • Department of Neurobiology and Neurophysiology, Universidad Católica de Valencia San Vicente Mártir, 46001 Valencia, Spain.
  • Faculty of Biological Sciences, Universidad de Valencia, 46100 Valencia, Spain.
  • Psychiatry Service, Doctor Peset University Hospital, FISABIO, 46017 Valencia, Spain.
  • Interuniversity Research Institute for Molecular Recognition and Technological Development (IDM), 46022 Valencia, Spain.

ORCID-Profile: Isis Gastaldo-Jordán, Marta Pardo

Förderung

  • Ministerio de Ciencia, Innovación y Universidades
  • Ministerio de Ciencia e Innovación

Zitieren

APA

Giménez, S., Millan, A., Mora-Morell, A., Ayuso, N., Gastaldo-Jordán, I., & Pardo, M. (2024). Advances in Brain Stimulation, Nanomedicine and the Use of Magnetoelectric Nanoparticles: Dopaminergic Alterations and Their Role in Neurodegeneration and Drug Addiction. Molecules. https://doi.org/10.3390/molecules29153580

Vancouver

Giménez S, Millan A, Mora-Morell A, Ayuso N, Gastaldo-Jordán I, Pardo M. Advances in Brain Stimulation, Nanomedicine and the Use of Magnetoelectric Nanoparticles: Dopaminergic Alterations and Their Role in Neurodegeneration and Drug Addiction. Molecules. 2024. doi:10.3390/molecules29153580

BibTeX
@article{Gimnez2024,
  author = {Giménez, Silvia and Millan, Alexandra and Mora-Morell, Alba and Ayuso, Noa and Gastaldo-Jordán, Isis and Pardo, Marta},
  title = {Advances in Brain Stimulation, Nanomedicine and the Use of Magnetoelectric Nanoparticles: Dopaminergic Alterations and Their Role in Neurodegeneration and Drug Addiction},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29153580}
}
Kostenlos starten →